Filter news
Share Article
Urenco enhances its social investment
16 June 2021 Global NewsUrenco has evolved its strategy for social investment, with a clear focus on multi-year partnerships with charitable organisations and enhanced alignment of our internship, educational and other social programmes with our wider sustainability priorities.
Our Board has approved an increase to the social investment budget and a programme has been developed as a significant element of our refreshed sustainability strategy, which will be communicated in our forthcoming Sustainability Report.
A Social Investment Committee has now been formed, comprising representatives from key areas of the business. It met for the first time last week, agreeing increased funding for the IAEA Marie Sklodowska-Curie Fellowship Programme.
The committee will actively collaborate to initiate partnerships, focusing on three workstreams:
• Education, skills and research
• Culture, health and social development
• Environment
We look forward to making further funding announcements in the near future.
Share Article
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries